Skip to content

Efficacy and Safety of Akshun ultra gel & Akshun pain roll- on in relieving various types of pain

Clinical evaluation of Akshun ultra gel & Akshun pain roll- on for preliminary safety and relieving various types of pain - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089199
Enrollment
50
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R52- Pain, unspecified

Interventions

Intervention1: Akshun ultra gel: Gaultheria fragrantissima -20% Mentha piperata -5% Cinnamomum camphora -2% Trachyspermum ammi -1% Eucalyptus globulus 1% Required Quantity of Gel will be applied Tw

Sponsors

Dr.JRKs Research and Pharmaceuticals Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Availability of the patients for the entire study period and their willingness to adhere to the protocol requirements as evidenced by signing the informed consent form (ICF) . 2) Patients in the age group between 18 to 55 years, both male and female. 3) Patients who have no evidence of life-threatening disease within 28 days prior to commencement of the study. 4) Patients suffering from cervical spondylitis, low back pain or pain in the joints of chronic nature. 5) Patients, who are willing to avoid sun bath, swimming in pool, prolonged sun exposure or artificial UV rays during the study. 6) Patients who are willing to not to take any other pain relieving products (topical and oral) including steroids during the study period

Exclusion criteria

Exclusion criteria: 1) Patients require definite systemic therapy 2) Patients who are allergic counter irritant based preparations 3) Patients who cannot comply with the protocol

Design outcomes

Primary

MeasureTime frame
i) Extent of relief Timepoint: Baseline, Day 15 and Day 30

Secondary

MeasureTime frame
i) Time required for perceivable relief ii) Frequency/ number of application needed iii) Duration of relief iv) Initial sensory feel vi) Duration of the sensory feel V) The indirect measurement of pain relief will be performed using thermal imaging & photography of colour Doppler change on the skin before & after application.Timepoint: Baseline, Day 15 & Day 30

Countries

India

Contacts

Public ContactDr Gayathri Sivakumar

DK Elite Health Care Centre

saheerose@gmail.com9843591097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026